| All Releases
|
|---|
 |
Cytori to Webcast Second Quarter Financial Results
Jul 30, 2010
|
9.8 KB
|
| |
SAN DIEGO, Jul 30, 2010 (GlobeNewswire via COMTEX News Network) -- Cytori Therapeutics (Nasdaq:CYTX) will host a webcast to discuss their second quarter financial results on Friday, August 6, 2010 at 10:30 AM Eastern Time. Prior to the webcast at approximately 7:00 AM Eastern Time on August 6, Cytori will post a shareholder letter to its Investor R...
|
|
|
Cytori's PureGraft(TM) System Receives European Approval for Fat Grafting Procedures
Jul 29, 2010
|
12.3 KB
|
| |
SAN DIEGO, Jul 29, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ: CYTX) has received European (CE Mark)
approval for the PureGraft(TM) 250/PURE System for autologous fat grafting
procedures, allowing Cytori to immediately commercialize the PureGraft(TM)
product line to physicians in Europe. PureGraft(TM) will be sold a...
|
|
|
Cytori Gains Stem Cell Device Approval in Europe for Breast Cancer Reconstruction and Soft Tissue Repair
Jul 27, 2010
|
13.2 KB
|
| |
SAN DIEGO, Jul 27, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ: CYTX) received expanded European approval
(CE Mark) for its Celution(R) System, a medical device that extracts and
separates stem and regenerative cells from a patient's own fat tissue.
The new indications include key medical applications such as breast ...
|
|
|
Breast Cancer Reconstruction Using Cell-Enriched Fat Grafts Shows Continued High Rates of Physician and Patient Satisfaction at 12 Months
Jun 17, 2010
|
14.6 KB
|
| |
SAN DIEGO, Jun 17, 2010 (BUSINESS WIRE) -- Interim results from a breast reconstruction trial show stem and
regenerative cell-enriched fat grafting resulted in a high sustained
rate of physician and patient satisfaction and persistent improvements
in overall outcomes of the procedure at six and 12 months.
Improvements in ou...
|
|
|
Cytori Secures $20 Million Loan Facility Led by GE Capital, Healthcare Financial Services
Jun 14, 2010
|
11.9 KB
|
| |
SAN DIEGO, Jun 14, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ: CYTX) entered into a $20 million secured
loan facility from GE Capital, Healthcare Financial Services, Oxford
Finance Corporation, and Silicon Valley Bank. The loan funded June 14,
2010.
The funds will be used to support Cytori's commercialization and
...
|
|
|
Cytori to Present at Three Upcoming Investor Conferences
May 25, 2010
|
9.9 KB
|
| |
SAN DIEGO, May 25, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) will present and provide a webcast of
its corporate presentations at three upcoming investor conferences. The
Company will be presenting at:
Noble Financial 6th Annual Equity Conference on June 7,
2010 at 11:30 AM ET
...
|
|
|
Cytori Sells First U.S. StemSource(R) Cell Bank
May 18, 2010
|
10.1 KB
|
| |
SAN DIEGO, May 18, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ: CYTX) has sold its first StemSource(R)
Cell Bank in the United States. The StemSource(R) Cell Bank is a suite of
products that offers patients a way to store their own adipose tissue,
or the stem and regenerative cells naturally occurring within their ow...
|
|
|
Cytori to Webcast Corporate Presentation at the MDB Capital Group Investor Conference on May 12, 2010
May 11, 2010
|
9.7 KB
|
| |
SAN DIEGO, May 11, 2010 (BUSINESS WIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will present and provide a
webcast of their corporate presentation at MDB Capital Bright Lights
Conference at 5:30 PM (EDT) on Wednesday, May 12, 2010 in San Francisco.
The audio webcast may be accessed under "Webcasts" in the Investor
Relat...
|
|
|
Cytori Reports Stem & Regenerative Cells from Body Fat Produce Statistically Significant Improvement in Heart Function in Chronic Ischemia Trial
May 7, 2010
|
16.8 KB
|
| |
SAN DIEGO, May 07, 2010 (BUSINESS WIRE) -- The first clinical trial of adipose (fat) tissue-derived stem and
regenerative cells (ADRCs) for the treatment of no-option chronic heart
disease patients showed the following: the procedure was safe and
feasible; it demonstrated a statistically significant improvement in
ma...
|
|
|
Cytori Reports Stem & Regenerative Cells from Body Fat Improve Outcomes in Heart Attack Clinical Trial; Plans Underway for European Multicenter Pivotal Trial
May 7, 2010
|
16.0 KB
|
| |
SAN DIEGO, May 07, 2010 (BUSINESS WIRE) -- The first clinical trial of adipose (fat) tissue-derived stem and
regenerative cells for the treatment of heart attacks showed a
substantial reduction in the size of injury to the heart, an improvement
in the amount of blood supply to the heart muscle, and a corresponding
fu...
|
|
|
Cytori Reports First Quarter Results
May 6, 2010
|
24.0 KB
|
| |
SAN DIEGO, May 06, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) is reporting its first quarter
financial results. More information on our commercial and clinical
progress is posted online in the 'May 2010 Shareholder Letter' at http://ir.cytoritx.com.
Key accomplishments for Cytori in the first quarter and year-to-date...
|
|
|
May 2010 Shareholder Letter
May 6, 2010
|
19.2 KB
|
| |
...
|
|
|
Cytori to Webcast First Quarter Financial Results
Apr 28, 2010
|
9.8 KB
|
| |
SAN DIEGO, Apr 28, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) will host a webcast to discuss their
first quarter financial results on Thursday, May 6, 2010 at 10:30 AM
Eastern Time. Prior to the webcast at approximately 7:00 AM Eastern Time
on May 6, Cytori will post a shareholder letter to its Investor
...
|
|
|
PureGraft(TM) Enters the Market as an Innovative New System for Safe, Fast and Reliable Fat Graft Processing
Apr 22, 2010
|
12.1 KB
|
| |
SAN DIEGO, Apr 22, 2010 (BUSINESS WIRE) -- Cytori announces the product launch of PureGraft 250, a revolutionary
fat grafting technology that standardizes the graft preparation process
for use in aesthetic body contouring at the American Society of
Aesthetic Plastic Surgeons (ASAPS) meeting.
"PureGraft is a game-changer in ...
|
|
|
Cytori to Webcast at the Future Leaders in the Biotech Industry Conference on April 8, 2010
Apr 1, 2010
|
9.7 KB
|
| |
SAN DIEGO, Apr 01, 2010 (BUSINESS WIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will present and provide a
webcast of their corporate presentation at BioCentury's Future Leaders
in the Biotech Industry conference at 11:00 AM (EST) on Thursday, April
8, 2010 in New York.
The audio webcast may be accessed under "Webcasts"...
|
|
|
Cytori Reports 2009 Financial Results
Mar 12, 2010
|
26.5 KB
|
| |
SAN DIEGO, Mar 12, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) is reporting its financial results for
the year ended December 31, 2009. More information on our commercial and
clinical progress is posted online in the 'March 2010 Shareholder
Letter' at http://ir.cytoritx.com/investorrelations/blog.
During 2009,...
|
|
|
Cytori Therapeutics Announces Spring 2010 Conference Schedule
Feb 26, 2010
|
9.7 KB
|
| |
SAN DIEGO, Feb 26, 2010 (BUSINESS WIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announces their spring 2010
medical and investor conference schedule. The full schedule may be
accessed from the following link in the Investor Relations section of
Cytori's website: http://ir.cytoritx.com/InvestorRelations/blog.cfm.
About Cy...
|
|
|
Cytori to Webcast Fourth Quarter Financial Results and Investor Presentation
Feb 24, 2010
|
10.1 KB
|
| |
SAN DIEGO, Feb 24, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ: CYTX) will host a webcast to discuss their
year-end and fourth quarter financial results on Friday, March 12, 2010
at 10:30 AM Eastern Time. Prior to the webcast at approximately 7:00 AM
Eastern Time on March 12, Cytori will post a shareholder letter to ...
|
|
|
Cytori's StemSource(R) Cell Bank to Be Installed at Leading Cosmetic & Reconstructive Surgery Network in Japan
Jan 27, 2010
|
11.5 KB
|
| |
SAN DIEGO, Jan 27, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ: CYTX) received an order for a StemSource(R)
Cell Bank from Cosmetic Surgery Seishin in Japan. The Cell Bank includes
a StemSource(R) processing system along with all other equipment,
software, database, and protocols required to cryopreserve patients' ow...
|
|
|
Cytori Issued U.S. Patent for Cell-Enriched Fat Grafting; New Patent Protects Key Cytori Market
Jan 26, 2010
|
11.9 KB
|
| |
SAN DIEGO, Jan 26, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) today received U.S. Patent No.
7,651,684 (the '684 patent) which covers the Company's methods for
delivering adipose-derived stem and regenerative cell-enriched fat
grafts into patients. The '684 patent specifically covers cell-enriched
fat ...
|
|
|